147 results
8-K
EX-10.1
SILO
SILO Pharma Inc
6 Jun 24
Silo Pharma Announces $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
4:52pm
of unaudited statements, to normal, immaterial, year-end audit adjustments.
(i) Material Changes; Undisclosed Events, Liabilities or Developments. Since
8-K
EX-99.1
pzdg u1fs5q97r
18 Oct 22
Entry into a Material Definitive Agreement
5:15pm
8-K
EX-10.2
dp3dsemd
18 Oct 22
Entry into a Material Definitive Agreement
5:15pm
8-K
5h9mz9un
30 Sep 22
Silo Pharma Announces Uplisting to Nasdaq Capital Market and Pricing of $5 Million Public Offering of Common Stock
8:45am
8-K
EX-1.1
nmbfd7j4e bq6
30 Sep 22
Silo Pharma Announces Uplisting to Nasdaq Capital Market and Pricing of $5 Million Public Offering of Common Stock
8:45am